FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

17814311000001107: Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 22-Sep 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
61343401000001116 Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
61343501000001117 Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Is a Product containing precisely terazosin (as terazosin hydrochloride) 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has active ingredient Terazosin hydrochloride false Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has specific active ingredient Terazosin hydrochloride true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Has basis of strength substance Terazosin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) 28 tablet Has AMP True Terazosin 5mg tablets (Phoenix Healthcare Distribution Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start